Every O.penVAPE product is infused with OrganaLabs certified oil- meaning you are getting a pure, consistent and balanced product every time.
Every batch of OrganaLAbs certified oil is extracted from the highest quality, locally grown cannabis.
The raw material is then processed through a super-critical, closed-loop C02 organic extraction process. This ensures that you are getting a safe and pure product
The process doesn’t stop there. Next the oil is triple refined with low heat, which helps preserve the naturally occurring terpenes. This method creates oil that is uniform in formulation and delivers repeatable, potent experience to the end user.
To top it all off, all of our cartridges are QA tested, giving us the lowest failure rate in the industry.
We provide a Lifetime Battery Warranty on all our products.
Medicinal Marijuana For Proven Pain Relief
For many people the consequences of living with pain is unimaginable. Medical Marijuana can relief pain. Whether we look at the United States Government Patent or the thousands of research articles the conclusion is the same. Despite the serious documented evidence that opiates have tremendous side effects doctors continue to write these prescriptions.
Timeless is strongly committed to establishing scientifically the benefits of medical marijuana for pain relief. After over 20 years of proven pain relief Timeless is now proud to bring our first pain relief product to market. The product is so good we decide to call it Majic. Timeless Majic has been scientifically proven and tested to have high anti-inflammatory agents. Applied as a topical rub, Timeless Majic can help reduce pain caused by inflammation.
The following is a list of medical conditions that may benefit from the use of medical marijuana. Please speak to your doctor to get a clear understanding.
Back & Neck Problems
Irritable Bowel Syndrome
Post-Traumatic Stress Disorder
Spinal Cord Injury/Disease
Humans have been using cannabis plants for medicinal and recreational purposes for thousands of years, but cannabinoids themselves were first purified from cannabis plants in the 1940s. The structure of the main active ingredient of cannabis plants – delta-9 tetrahydrocannabinol (THC) – was discovered in the 60s. It wasn’t until the late 1980s that researchers found the first cannabinoid receptor, followed shortly by the discovery that we create cannabinoid-like chemicals within our own bodies, known as endocannabinoids.
We have two main types of cannabinoid receptor, CB1 and CB2, which are found in different locations and do different things. CB1 is mostly found on cells in the nervous system, including certain areas of the brain and the ends of nerves throughout the body, while CB2 receptors are mostly found in cells from the immune system. Because of their location in the brain, it’s thought that CB1 receptors are responsible for the infamous ‘high’ (known as psychoactive effects) resulting from using cannabis.
There is also a third family of cannabinoid receptors, known as GPR, of which the main type is GPR55. Less is known about these receptors, but researchers are investigating them to see if they could lead to effective approaches for treating cancer.
Over the past couple of decades scientists have found that endocannabinoids and cannabinoid receptors are involved in a vast array of functions in our bodies, including helping to control brain and nerve activity (including memory and pain), energy metabolism, heart function, the immune system and even reproduction. Because of this molecular multitasking, they’re implicated in a huge range of illnesses, from cancer to neurodegenerative diseases.
CBD is non-psychoactive.
Unlike THC, CBD does not cause a high. While this makes CBD a poor choice for recreational users, it gives the chemical a significant advantage as a medicine, since health professionals prefer treatments with minimal side effects.
CBD is non-psychoactive because it does not act on the same pathways as THC. These pathways, called CB1 receptors, are highly concentrated in the brain and are responsible for the mind-altering effects of THC.
A 2011 review published in Current Drug Safety concludes that CBD “does not interfere with several psychomotor and psychological functions.” The authors add that several studies suggest that CBD is “well tolerated and safe” even at high doses.
CBD has a wide range of medical benefits
Although CBD and THC act on different pathways of the body, they seem to have many of the same medical benefits. According to a 2013 review published in the British Journal of Clinical Pharmacology, studies have found CBD to possess the following medical properties:
|BMedical Properties of CBD||Effects|
|Antiemetic||Reduces nausea and vomiting|
|Anticonvulsant||Suppresses seizure activity|
|Antipsychotic||Combats psychosis disorders|
|Anti-inflammatory||Combats inflammatory disorders|
|Anti-oxidant||Combats neurodegenerative disorders|
|Anti-tumoral/Anti-cancer||Combats tumor and cancer cells|
|Anxiolytic/Anti-depressant||Combats anxiety and depression disorders|
Unfortunately, most of this evidence comes from animals, since very few studies on CBD have been carried out in human patients.
Many pharmaceutical versions of CBD are recently being developed by drug companies around the world. Clinical trials are currently underway testing the effectiveness of CBD as a treatment for schizophrenia and certain types of epilepsy.
CBD is still illegal
On the other hand, the U.S. Food and Drug Administration recently approved a request to trial a pharmaceutical version of CBD in children with rare forms of epilepsy. The drug is made by GW Pharmaceuticals and is called Epidiolex.
According to the company, the drug consists of “more than 98 percent CBD, trace quantities of some other cannabinoids, and zero THC.” GW Pharmaceuticals makes another cannabis-based drug called Sativex, which has been approved in over 24 countries for treating multiple sclerosis.
A patent awarded to the U.S. Health and Human Services in 2003 (US6630507) also covers the use of CBD as a treatment for various neurodegenerative and inflammatory disorders.